The Fas-Fas ligand (FasL) pathway has been demonstrated to contribute to severe epithelial damage that occurs in the acute respiratory distress syndrome (ARDS), a disease characterized by the death of lung epithelial cells with resultant loss of lung barrier function. This evidence concerns the gene FASLG and acute respiratory distress syndrome.